Skip to content

NEXTBio Capital

NEXTBio Capital is a VC fund. It joined 1 round tracked by OSH in the last 90 days.

What they look for

Not published yet. OSH fills this in from NEXTBio Capital's own site, or from its deals once OSH tracks them.

Activity

Deals, 90 days
1
Deals, 12 months
1
Led, 12 months
0
Median disclosed round
$173M

Frequent co-investors:Scion Life SciencesVenbio PartnersOrbiMedRTW InvestmentsSurveyor Capital

Computed from OSH Rounds. A deal is a round the investor led or joined.

Portfolio from OSH Rounds

  • Nov 17 · Series B

    Led by Scion Life Sciences, Venbio Partners, OrbiMed · with RTW Investments, +7

    1 source

Questions and answers

How active is NEXTBio Capital?

In OSH Rounds, NEXTBio Capital joined 1 round in the last 90 days and 1 in the last 12 months, leading 0.

Something wrong? Suggest a correction.

Sources

  1. 1.Sickle Cell Drug: Marrow Raises $173 Million Without Releasing Anemia or Selectivity Data — techtimes.com, Nov 17, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Nov 20, 2026